All Stories

May 4, 2017| Healthcare News /

Heart patient stent alert

Earlier this week, Abbott Vascular Australia announced that the heart device Absorb Bioresorbable Vascular Scaffold system will no longer be used as research has shown it is linked to elevated rates of heart attacks and blood clots.

The product is an absorbable heart stent that is inserted into an artery around the heart due to narrowing of that artery, so that blood flow to the heart would be improved.